Home › Funds › Millennium Management › ACRS
Millennium Management position in ACRS
ACLARIS THERAPEUTICS INC · Health Care
Latest position (Q2 2026)523.89K sh
Reported value held$2.77M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 371.19K | $6.68M | New |
| Q4 2021 | 402.51K | $5.85M | Add |
| Q1 2022 | 56.21K | $969.00K | Reduce |
| Q2 2022 | 198.79K | $2.77M | Add |
| Q3 2022 | 203.91K | $3.21M | Add |
| Q4 2022 | 207.90K | $3.27K | Add |
| Q1 2023 | 110.86K | $897 | Reduce |
| Q2 2023 | 877.08K | $9.10M | Add |
| Q3 2023 | 2.13M | $14.56M | Add |
| Q4 2023 | 3.48M | $3.65M | Add |
| Q1 2024 | 3.27M | $4.06M | Reduce |
| Q2 2024 | 3.34M | $3.67M | Add |
| Q3 2024 | 3.01M | $3.46M | Reduce |
| Q4 2024 | 1.96M | $4.86M | Reduce |
| Q1 2025 | 4.13M | $6.33M | Add |
| Q2 2025 | 3.84M | $5.45M | Reduce |
| Q3 2025 | 1.55M | $2.95M | Reduce |
| Q4 2025 | 1.05M | $3.17M | Reduce |
| Q1 2026 | 756.13K | $2.84M | Reduce |
| Q2 2026 | 523.89K | $2.77M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ACRS
- BlackRock Inc 10.04M sh · $53.10M · Q2 2026
- Vanguard Group 6.50M sh · $19.57M · Q4 2025
- Geode Capital Management 3.19M sh · $16.88M · Q2 2026
- Balyasny Asset Management 2.02M sh · $10.70M · Q2 2026
- Deutsche Bank AG 1.04M sh · $5.51M · Q2 2026
- Northern Trust Corp 998.76K sh · $5.28M · Q2 2026
- Renaissance Technologies 817.53K sh · $4.32M · Q2 2026
- Goldman Sachs Group 609.16K sh · $3.22M · Q2 2026
- JPMorgan Chase & Co 468.96K sh · $2.35M · Q2 2026
- D. E. Shaw & Co 414.50K sh · $2.19M · Q2 2026
- Charles Schwab Investment Management 346.06K sh · $1.83M · Q2 2026